Literature DB >> 22348201

Asthma in the elderly and aging societies in Asia Pacific.

Sohei Makino1.   

Abstract

Entities:  

Year:  2012        PMID: 22348201      PMCID: PMC3269596          DOI: 10.5415/apallergy.2012.2.1.1

Source DB:  PubMed          Journal:  Asia Pac Allergy        ISSN: 2233-8276


× No keyword cloud information.
Asthma is a chronic inflammatory disease of the airway with airway hyperresponsiveness and constriction. Asthma occurs globally and affects people of all ages. The world's population is increasingly becoming older. They are also facing increase in non-communicable diseases including asthma and chronic obstructive pulmonary disease.

Global facts for asthma (from asthma facts [1] and key messages [2])

Some 235-300 million people currently suffer from asthma. The prevalence of asthma has increased following transition to a modern, urban lifestyle [3, 4]. Globally, 250,000 people die of asthma every year. Asthma deaths are related to lack of proper treatment. In Japan, 90% of deaths from asthma occur in people 60 years and over [5]. Most asthma-related deaths occur in low- and lower-middle income countries. Appropriate management of asthma can enable people to enjoy a good quality of life. Treatment for asthma is not available to all people who have the disease. The elderly with asthma often have irreversible airway obstruction due to severe airway remodeling or chronic obstructive pulmonary disease [6].

Selected facts on global aging [7]

The world will soon have more older people than children. Since asthma affects all ages, the number of elderly with asthma will also increase and therefore, caring for the elderly is more and more important. The world's elderly population - people 60 years of age and older- is the fastest growing age group. Aging is a global phenomenon and increases in the population of the elderly is occurring in parallel with rapid urbanization. In 2007, more than half of the world's population lives in cities. By 2050, close to 80% of all deaths are estimated to occur in people over 60 years of age. Health expenditures increase with age but are concentrated in the last two years of life, regardless of how old someone is. As people live longer, it is important to ensure these added years are healthy so that health-care costs can be kept manageable.

Asthma management guidelines [4, 8-10]

In 1993, Global Initiative for Asthma and the Japanese Asthma Prevention and Management Guidelines (JGL) were initiated. The effectiveness of JGL can be evaluated by a decrease in deaths from asthma after its inception compared to prior implementation of the JGL. In Japan, deaths from asthma started to decrease continuously around 1997 through 2010. The total number of deaths from asthma between 1993 to 1998 was approximately 5,900, and it was as low as 1765 in 2010 [5, 8]. Implementation of asthma management guidelines should be effective in decreasing deaths from asthma in developing countries in the Asia Pacific.

Burden of asthma in the elderly of the Asia Pacific [11]

Asia Pacific is a developing area with some developed countries. Economic progress can increase the elderly population by a prolonged life expectancy. Prolonged life expectancy and urbanization are thought to increase asthma in the elderly. Active elderly, non-asthma or asthma, represents a resource of family life, community and economics. The elderly can contribute to activities in society through their many experiences. Active elderly asthmatics can manage themselves with less medical expenses. Indeed, emergency treatment or hospitalization is expensive [4, 12]. Treatment of asthma in the elderly is similar for all other ages. Elderly patients and their families should be educated to adhere to medications for asthma as well as control environmental pollution [6, 13]. Regional support and continued care of elderly asthmatics should be encouraged by following asthma managing guidelines [14].
  7 in total

Review 1.  The global burden of asthma: executive summary of the GINA Dissemination Committee report.

Authors:  Matthew Masoli; Denise Fabian; Shaun Holt; Richard Beasley
Journal:  Allergy       Date:  2004-05       Impact factor: 13.146

Review 2.  Epidemiology of asthma.

Authors:  Sohei Makino; Mitsuru Adachi; Yukihiro Ago; Kazuo Akiyama; Minoru Baba; Yosuke Egashira; Masaki Fujimura; Takeshi Fukuda; Kenshi Furusho; Yoji Iikura; Hiroshi Inoue; Koji Ito; Itsuo Iwamoto; Junzaburo Kabe; Yuichiro Kamikawa; Yoshikazu Kawakami; Norio Kihara; Satoshi Kitamura; Koichiro Kudo; Kenji Mano; Takehido Matsui; Haruki Mikawa; Seishiro Miyagi; Terumasa Miyamoto; Yutaka Morita; Yukio Nagasaka; Takemasa Nakagawa; Shigenori Nakajima; Tsugio Nakazawa; Sankei Nishima; Ken Ohta; Takao Okubo; Hiroki Sakakibara; Yasuyuki Sano; Keisuke Shinomiya; Kenzo Takagi; Kiyoshi Takahashi; Gen Tamura; Hisao Tomioka; Kyoichiro Yoyoshima; Kazuharu Tsukioka; Nobuo Ueda; Michio Yamakido; Susumo Hosoi; Hironori Sagara
Journal:  Int Arch Allergy Immunol       Date:  2005       Impact factor: 2.749

Review 3.  Pharmacologic control of asthma.

Authors:  Sohei Makino; Mitsuru Adachi; Yukihiro Ago; Kazuo Akiyama; Minoru Baba; Yosuke Egashira; Masaki Fujimura; Takeshi Fukuda; Kenshi Furusho; Yoji Iikura; Hiroshi Inoue; Koji Ito; Itsuo Iwamoto; Junzaburo Kabe; Yuichiro Kamikawa; Yoshikazu Kawakami; Norio Kihara; Satoshi Kitamura; Koichiro Kudo; Kenji Mano; Takehido Matsui; Haruki Mikawa; Seishiro Miyagi; Terumasa Miyamoto; Yutaka Morita; Yukio Nagasaka; Takemasa Nakagawa; Shigenori Nakajima; Tsugio Nakazawa; Sankei Nishima; Ken Ohta; Takao Okubo; Hiroki Sakakibara; Yasuyuki Sano; Keisuke Shinomiya; Kenzo Takagi; Kiyoshi Takahashi; Gen Tamura; Hisao Tomioka; Kyoichiro Yoyoshima; Kazuharu Tsukioka; Nobuo Ueda; Michio Yamakido; Susumo Hosoi; Hironori Sagara
Journal:  Int Arch Allergy Immunol       Date:  2005       Impact factor: 2.749

4.  Asthma in the elderly: What we do not know yet but should find out.

Authors:  Charles E Reed
Journal:  J Allergy Clin Immunol       Date:  2011-09       Impact factor: 10.793

5.  Evolution of asthma concept and effect of current asthma management guidelines.

Authors:  Sohei Makino; Hironori Sagara
Journal:  Allergy Asthma Immunol Res       Date:  2010-05-06       Impact factor: 5.764

6.  Cost of hospitalizing asthma patients in a regional hospital in Thailand.

Authors:  Kittisak Chuesakoolvanich
Journal:  Respirology       Date:  2007-05       Impact factor: 6.424

7.  Continuity of care for elderly patients with diabetes mellitus, hypertension, asthma, and chronic obstructive pulmonary disease in Korea.

Authors:  Jae Seok Hong; Hee Chung Kang; Jaiyong Kim
Journal:  J Korean Med Sci       Date:  2010-08-14       Impact factor: 2.153

  7 in total
  3 in total

1.  Sinobronchial allergic mycosis syndrome in an elderly male.

Authors:  Eisuke Mochizuki; Shun Matsuura; Tsutomu Kubota; Yasutaka Mochizuka; Kyohei Oishi; Hyogo Naoi; Masahiro Uehara; Shinichiro Mikura; Miyuki Nagaoka; Masaru Tsukui; Naoki Koshimizu; Ichirota Nameki
Journal:  Allergy Asthma Clin Immunol       Date:  2019-06-04       Impact factor: 3.406

Review 2.  Respiratory allergies in the elderly: findings from the Korean Longitudinal Study on Health and Aging phase I study (2005-2006).

Authors:  Woo-Jung Song; Yoon-Seok Chang
Journal:  Asia Pac Allergy       Date:  2017-10-30

3.  Asia Pacific Allergy: it's been five years!

Authors:  Yoon-Seok Chang
Journal:  Asia Pac Allergy       Date:  2016-01-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.